Form 8-K - Current report:
SEC Accession No. 0001558370-22-015785
Filing Date
2022-11-01
Accepted
2022-11-01 16:05:40
Documents
12
Period of Report
2022-10-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K kala-20221031x8k.htm   iXBRL 8-K 32329
  Complete submission text file 0001558370-22-015785.txt   152491

Data Files

Seq Description Document Type Size
2 EX-101.SCH kala-20221031.xsd EX-101.SCH 3126
3 EX-101.LAB kala-20221031_lab.xml EX-101.LAB 15918
4 EX-101.PRE kala-20221031_pre.xml EX-101.PRE 10053
6 EXTRACTED XBRL INSTANCE DOCUMENT kala-20221031x8k_htm.xml XML 4918
Mailing Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476
Business Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476 781-996-5252
Kala Pharmaceuticals, Inc. (Filer) CIK: 0001479419 (see all company filings)

EIN.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38150 | Film No.: 221350208
SIC: 2834 Pharmaceutical Preparations